[144] First Horizon Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 notice for First Horizon Corporation (FHN) shows a proposed sale of 100,000 common shares through Raymond James & Associates on 08/22/2025, with an aggregate market value of $2,244,514.05 and 507,747,624 shares outstanding. The filing lists the securities as previously acquired as restricted stock across multiple grant dates from 02/14/2015 to 05/12/2021, totaling recorded lots (e.g., 3,447; 15,316; 9,989; 6,242; 15,520; 18,267; 12,764; 11,979). It also discloses recent sales by David T. Popwell on 07/22/2025 totaling 38,010 shares for gross proceeds of $843,834.52. The filer certifies no undisclosed material adverse information.

Positive

• Full disclosure of proposed sale including broker, date, share count, and market value
• Origin of shares documented (restricted stock grant dates from 2015–2021), supporting transparency

Negative

• Insider selling activity (100,000 proposed shares and 38,010 recently sold) which may be perceived negatively by some investors
• No trading plan date disclosed in the remarks that would indicate scheduled liquidity rather than opportunistic selling

Insights

Securities Analyst

TL;DR: Insider plans to sell 100,000 shares (~$2.24M) after prior disposals, likely routine Rule 144 liquidity management.

The filing documents a proposed Rule 144 sale of 100,000 common shares with an aggregate value of $2.24M via Raymond James on 08/22/2025. The shares originated from multiple restricted stock grants between 2015 and 2021, indicating long-held compensation rather than recent acquisitions. Recent open-market sales by David T. Popwell on 07/22/2025 totaled 38,010 shares for $843,834.52, showing active disposition activity ahead of the proposed block. For investors, this is a disclosure of executive/insider selling under Rule 144 rather than a corporate operational update; absent other company disclosures, the information is procedural and liquidity-related.

Corporate Governance Expert

TL;DR: Multiple past restricted grants being monetized; filing contains standard attestations and no unusual restrictions disclosed.

The schedule of acquisitions shows restricted stock grants from 2015 through 2021 in modest lot sizes, consistent with compensation vesting. The notice includes the statutory representation that the seller is unaware of undisclosed material adverse information. No trading plan date or additional restrictions are provided in the remarks. This looks like routine compliance with Rule 144 for an insider sale and does not by itself indicate governance concerns, though continued or large-scale selling could be monitored.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	100000	2244514.05	507747624	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2015	Restricted Stock	Issuer			3447	02/14/2015	Incentive Corp
Common	04/29/2015	Restricted Stock	Issuer			15316	04/29/2015	Incentive Corp
Common	04/27/2016	Restricted Stock	Issuer			9989	04/27/2016	Incentive Corp
Common	04/26/2017	Restricted Stock	Issuer			6242	04/26/2017	Incentive Corp
Common	10/17/2018	Restricted Stock	Issuer			15520	10/17/2018	Incentive Corp
Common	03/02/2019	Restricted Stock	Issuer			18267	03/02/2019	Incentive Corp
Common	03/02/2021	Restricted Stock	Issuer			12764	03/02/2021	Incentive Corp
Common	05/12/2021	Restricted Stock	Issuer			11979	05/12/2021	Incentive Corp

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David T Popwell 36 Wychewood Dr Memphis TN 38117	Common	07/22/2025	12475	276972.47
David T Popwell 36 Wychewood Dr Memphis TN 38117	Common	07/22/2025	25535	566862.05

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for FHN announce?

It announces a proposed Rule 144 sale of 100,000 First Horizon common shares valued at $2,244,514.05 to be executed on 08/22/2025 through Raymond James.

Who previously sold shares according to the filing?

The filing reports that David T. Popwell sold 38,010 shares on 07/22/2025 for gross proceeds of $843,834.52.

What is the origin of the shares to be sold?

The shares were acquired as restricted stock grants from the issuer on multiple dates between 02/14/2015 and 05/12/2021.

Which broker is handling the proposed sale?

The broker listed is Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL.

Does the filer assert any undisclosed material information?

Yes, the filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.